Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
- Su Yeon Yu
- , Dae Hyup Koh
- , Miyoung Choi
- , Seungeun Ryoo
- , Kyungmin Huh
- , Joon Sup Yeom
- , Young Kyung Yoon*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
33
Link opens in a new tab
Citations
(Scopus)